The blood cancer multiple myeloma, which involves infection-fighting plasma cells in the bone marrow, affects only about 1% of all cancers -- predominantly individuals over age 65. The disease ...

Patients with relapsed/refractory (R/R) multiple myeloma and lower socioeconomic status reported significantly worse quality of life and a higher burden of symptoms, according to Francesco Sparano, ...

Around 1,500 people with multiple myeloma are set to benefit from the treatment, which combines belantamab mafodotin (brand name Blenrep) with bortezomib and dexamethasone.

Dr. Joseph Mikhael discusses the overlooked symptoms of multiple myeloma in honor of Myeloma Awareness Month. March is Myeloma Awareness Month, a time to recognize the subtle but serious symptoms of ...

"Multiple myeloma is a malignancy (cancer) often associated with symptoms such as anemia, hypercalcemia and renal (kidney) failure. Smoldering multiple myeloma has many features of malignancy ...

Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...

Renal failure in multiple myeloma typically occurs when the kidneys fail to filter waste products from the blood, leading to ...

During a live event, Samuel M. Rubinstein, MD, discussed the outcomes from the KarMMa-3 trial and real-world patients ...

The NHS in England will be the first health system in the world to roll-out a ‘trojan horse’ targeted therapy for blood cancer patients which could halt the disease’s progression by nearly three times ...

Quesnel's Cyndi Logan spent $10,000 last time she received treatment, now she's worried the cost will be higher for the next ...